Reported Bone Pain in Patients with Breast Cancer Receiving Taxane-Based Chemotherapy in Clinical Trials of Pegfilgrastim

被引：0
|
作者：
Schwartzberg, L. S.
Mo, M.
Harms, R.
Vogel, C. L.
机构：
[1] West Clin, Memphis, TN USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Lynn Canc Inst W, Canc Res Network & Aptium Oncol, Boca Raton, FL USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：576S / 576S
页数：1
相关论文
共 50 条
  • [41] Clinical Outcomes and Predictors of Pathological Response in Triple Negative Breast Cancer Patients Receiving Anthracycline/Taxane-Based Neoadjuvant Therapy
    Ciftci, Mehmet Sabri
    Ucaner, Burak
    Buldanli, Mehmet Zeki
    Hancerliogullari, Oguz
    Kaymak, Sahin
    Celik, Ertugrul
    INDIAN JOURNAL OF SURGERY, 2025,
  • [42] Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer
    Chan, Arlene
    Willsher, Peter C.
    Hastrich, Diana J.
    Anderson, James
    Barham, Tony
    Latham, Bruce
    Redfern, Andrew
    Van der Schaaf, Agatha
    Thomson, Jacqui
    Joseph, David
    Ingram, David
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (01) : 62 - 70
  • [43] Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials
    Sibylle Loibl
    Gunter von Minckwitz
    Nadia Harbeck
    Wolfgang Janni
    Dirk Elling
    Manfred Kaufmann
    Holm Eggemann
    Valentina Nekljudova
    Harald Sommer
    Marion Kiechle
    Sherko Kümmel
    Breast Cancer Research, 10
  • [44] Cisplatin/taxane or carboplatin/taxane-based chemotherapy in advanced cervical cancer
    Petrelli, F.
    Lorusso, D.
    Coinu, A.
    Cabiddu, M.
    Ghilardi, M.
    Borgonovo, K.
    Cremonesi, M.
    Raspagliesi, F.
    Barni, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S729 - S730
  • [45] Sarcopenia as a predictor of survival in patients with epithelial ovarian cancer (EOC) receiving platinum and taxane-based chemotherapy.
    Staley, Stuart-Allison Moffat
    Tucker, Katherine
    Newton, Meredith
    Ertel, Michelle
    Zhang, Yingao
    Doherty, Irene
    Gehrig, Paola A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Clinical characteristics of colitis induced by taxane-based chemotherapy
    Chen, Ellie
    Abu-Sbeih, Hamzah
    Thirumurthi, Selvi
    Mallepally, Niharika
    Khurana, Shruti
    Wei, Dongguang
    Altan, Mehmet
    Morris, Van K.
    Tan, Dongfeng
    Barcenas, Carlos H.
    Wang, Yinghong
    ANNALS OF GASTROENTEROLOGY, 2020, 33 (01): : 59 - +
  • [47] Visceral adiposity as a predictor of survival in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy.
    Staley, Stuart-Allison Moffat
    Tucker, Katherine
    Oldan, Jorge
    Moore, Dominic T.
    Newton, Meredith
    Ertel, Michelle
    West, Lindsay
    Bae-Jump, Victoria
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer
    Rier, Hanah N.
    Jager, Agnes
    Sleijfer, Stefan
    van Rosmalen, Joost
    Kock, Marc C. J. M.
    Levin, Mark-David
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 95 - 105
  • [49] Natural history of postural instability in breast cancer patients treated with taxane-based chemotherapy: A pilot study
    Monfort, Scott M.
    Pan, Xueliang
    Patrick, Robyn
    Singaravelu, Janani
    Loprinzi, Charles L.
    Lustberg, Maryam B.
    Chaudhari, Ajit M. W.
    GAIT & POSTURE, 2016, 48 : 237 - 242
  • [50] Body mass index as a predictive factor for efficacy of taxane-based chemotherapy in early breast cancer patients
    Garcia-Saenz, J. A.
    Spera, G.
    Pollan, M. A.
    Bermejo, B.
    Ruiz Borrego, M.
    Chan, A.
    Martin Jimenez, M.
    Guerrero Zotano, A. L.
    Calvo-Martinez, L.
    Rodriguez-Lescure, A.
    Arcusa Lanza, A.
    Chap, L. I.
    Crown, J. P.
    Bee-Munteanu, V.
    Casas, M.
    Polonio, O.
    Slamon, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S283 - S284
12345